Skip to content
PIL Logo

Dantrium 25mg and 100mg Capsules

Last Updated on eMC 07-Dec-2016 View document  | Norgine Limited Contact details

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC.  For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 07-Dec-2016 and displayed until Current

Reasons for adding or updating:

  • Change to section 6 - date of revision
  • Improved presentation of PIL
  • Change to section 4 - possible side effects
  • Change to section 4 - how to report a side effect

Updated on 29-Jan-2016 and displayed until 07-Dec-2016

Reasons for adding or updating:

  • Change to section 2 - excipient warnings
  • Change to section 6 - what the product contains
  • Change to section 6 - what the product looks like and pack contents
  • Change to section 6 - date of revision

Updated on 23-May-2012 and displayed until 29-Jan-2016

Reasons for adding or updating:

  • Change of inactive ingredient
  • Change to appearance of the medicine
  • Change to packaging
  • Change to date of revision

Updated on 09-Mar-2011 and displayed until 23-May-2012

Reasons for adding or updating:

  • New PIL for eMC ie a PIL for an existing product but one that is new to the eMC

Company contact details

Norgine Limited

Company image
Address

Norgine House, Widewater Place, Moorhall Road, Harefield, Middlesex, UB9 6NS

Fax

+44 (0)1895 825 865

Medical Information e-mail
Telephone

+44 (0)1895 826 600

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?

Active ingredients

dantrolene sodium

Legal categories

POM - Prescription Only Medicine

This site uses cookies. By continuing to browse the site you are agreeing to our policy on the use of cookies. Continue